Elementary phenotypes in the neurobiological and genetic study of schizophrenia

Biological Psychiatry

Volumn 46, Issue 1, 1999, Pages 8-18

  Adler, Lawrence E ^a,b   Freedman, Robert ^a,b   Ross, Randal G ^a,b   Olincy, Ann ^a,b   Waldo, Merilyne C ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Auditory evoked potentials; Childhood onset schizophrenia; Eye movements; Genetic segregation; Neuronal inhibition; Schizophrenia physiology

Indexed keywords

CHILDHOOD DISEASE; EVOKED AUDITORY RESPONSE; EYE MOVEMENT; GENETICS; HUMAN; NERVE CELL INHIBITION; NEUROBIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

ATTENTION; BRAIN; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 15; EVOKED POTENTIALS, AUDITORY; HUMANS; LINKAGE (GENETICS); NICOTINE; PHENOTYPE; RECEPTORS, CHOLINERGIC; RECEPTORS, NICOTINIC; RISK FACTORS; SACCADES; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 0033032776     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00085-2     Document Type: Review

References (139)

1. Adler L.E., Gerhardt G., Franks R., et al. Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Res. 31:1990;297-309.
2. Adler L.E., Hoffer L.D., Nagamoto H.T., Waldo M.C., Kisley M.A., Griffith J.M. Yohimbine impairs P50 auditory sensory gating in normal subjects. Neuropsychopharmacology. 10:1994;249-257.
3. Adler L.E., Hoffer L.D., Wiser A., Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry. 150:1993;1856-1861.
4. Adler L.E., Hoffer L.D., Griffith J.M., Waldo M., Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry. 32:1992;607-616.
5. Adler LE, Nagamoto N, Drebing C, Bronson J (1991): Impaired auditory sensory gating in patients with 20 years of combat post-traumatic stress disorder and depression. American Psychiatric Association, New Orleans, May, 1991.
6. Adler L.E., Olincy A., Waldo M., et al. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull. 24:1998;189-202.
7. Adler L.E., Pachtman E., Franks R., Pecevich M., Waldo M.C., Freedman R. Neurophysiological evidence for a deficit in inhibitor mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry. 17:1982;639-654.
8. Adler L.E., Pang K., Gerhardt G., Rose G.M. Modulation of the gating of auditory evoked potentials by norepinephrine pharmacological evidence obtained using a selective neurotoxin . Biol Psychiatry. 24:1988;179-190.
9. Adler L.E., Rose G.M., Freedman R. Neurophysiologic studies of sensory gating in rats Effects of amphetamine, phecyclidine and haloperidol . Biol Psychiatry. 21:1986;787-798.
10. Adler L.E., Waldo M., Tatcher A., Cawthra E., Baker N. Lack of relationship of auditory sensory gating defects to negative symptoms in schizophrenia. Schizophr Res. 3:1990;131-138.
11. Alaghband-Rad J., McKenna K., Gordon C.T., et al. Childhood-onset schizophrenia The severity of premorbid course . J Amer Acad Child Adolesc Psychiatry. 34:1995;1273-1283.
12. Diagnostic and Statistical Manual of Mental Disorders. fourth edition. 1994;APA Press, Inc, Washington, DC.
13. Arciniegas DB, Adler LE, Topkoff JL, Cawthra E, Filley CM, Riete ML (1999): Attention and memory dysfunction after traumatic brain injury: Cholinergic mechanisms, sensory gating, and a hypothesis for further investigation. Brain Injury, in press.
14. Arolt V., Lencer R., Nolte A., et al. Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. Am J Med Genet. 67:1996;564-579.
15. Arpaia J.P., Isenhart R., Sandman C.A. A characterization of a single-trial adaptive filter and its implementation in the frequency domain. Electroencephalogr Clin Neurophysiol. 73:1989;362-368.
16. Baker N., Adler L.E., Franks R.D., et al. Neurophysiological assessment of sensory gating in psychiatric inpatients comparison between schizophrenia and other diagnoses . Biol Psychiatry. 22:1987;603-617.
17. Benes F.M. Corticolimbic Circuitry and the development of psychopathology during childhood and adolescence. Krasnegor N.A., Lyon G.R., Goldman-Rakic P.S. Development of the Prefrontal Cortex Evolution, Neurobiology, and Behavior . 1997;211-239 Paul H. Brookes Publishing Co, Baltimore.
18. Bickford P.C., Wear K.D. Restoration of sensory gating of auditory evoked response by nicotine in fimbria-fornix lesioned rats. Brain Res. 705:(1-2):1995;235-240.
19. Bickford-Wimer P.C., Nagamoto H., Johnson R., et al. Sensory gating in hippocampal neurons A model system in the rat . Biol Psychiatry. 27:1990;183-192.
20. Blackwood D.H.R., St. Clair D.M., Muir W.J., Duffy J.C. Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Arch Gen Psychiatry. 48:1991;899-909.
21. Boutros N.N., Zouridakis G., Overall J. Replication and extension of P50 findings in schizophrenia. Clin Electroencephalogr. 22:1991;40-45.
22. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry. 47:1990;181-188.
23. Breese C.R., Adams C., Logel J., et al. Comparison of the regional expression of nicotinic acetylcholine receptor α7 mRNA and [125]-α-bungarotoxin binding in the human postmortem brain. J Comp Neurol. 387:1997;385-398.
24. Breese C.R., Marks M.J., Logel J., et al. Effect of smoking history on [3H] nicotine binding in human postmortem brain. J Pharmacol Exper Ther. 282:(1):1997;7-13.
25. Cardenas V.A., Gerson J., Fein G. The reliability of P50 suppression as measured by the conditioning/testing ratio is vastly improved by dipole modeling. Biol Psychiatry. 33:1993;335-344.
26. Chapman C.R., Colpitts Y.H., Mayenko J.K., Gaglioardi G.J. Rate of stimulus repetition changes evoked potential amplitude Dental and auditory modalities compared . Exp Brain Res. 43:1981;246-252.
27. Chini B., Raimond E., Elgoyhen A.B., Moralli D., Balzaretti M., Heinemann S. Molecular cloning and chromosomal localization of human α7-nicotinic receptor subunit gene (CHRNA7). Genomics. 19:1994;379-381.
28. Clementz B.A., Geyer M.A., Braff D.L. P50 suppression among schizophrenia and normal comparison subjects A methodological analysis . Biol Psychiatry. 41:1997;1035-1044.
29. Clementz B.A., Geyer M.A., Braff D.L. Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr Res. 30:1998;71-80.
30. Clementz B.A., Geyer M.A., Braff D.L. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry. 155:1998;1691-1694.
31. Coon H., Plaetke R., Holik J., et al. Use of a neurophysiological trait in linkage analysis of schizophrenia. Biol Psychiatry. 34:1993;277-289.
32. Cornblatt B.A., Keilp J.G. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull. 20:1994;31-46.
33. Cullum C.M., Harris J.G., Waldo M.C., et al. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophr Res. 10:1993;131-141.
34. Davis H., Mast T., Yoshie N., Zerlin S. The slow response of the human cortex to auditory stimuli. Recovery process. Electroencephalogr Clin Neurophysiol. 21:1966;105-113.
35. De Amicis L.A., Wagstaff D.A., Cromwell R. Reaction time crossover as a marker of schizophrenia and of higher functioning. J Nerv Ment Dis. 174:1986;177-179.
36. Eccles J.C. The Inhibitory Pathways of the Central Nervous System. 1969;University Press, Liverpool.
37. Elston RC (1996): SIBPAL, Statistical Analysis for Genetic Epidemiology (Case Western Reserve, Cleveland, Ohio), version 2.7.
38. Erwin R.J., Buchwald J.S. Midlatency auditory evoked responses Differential recovery cycle characteristics . Electroencephalogr Clin Neurophysiol. 64:1986;417-423.
39. Erwin R.J., Buchwald J.S. Midlatency auditory evoked responses in the human and the cat model. Electroencephalogr Clin Neurophysiol Suppl. 40:1987;461-467.
40. Erwin R.J., Mawhinney-Hee M., Gur R.C., Gur R.E. Midlatency auditory evoked responses in schizophrenia. Biol Psychiatry. 30:1991;430-442.
41. Erwin R.J., Stasel D., Gur R.E. Effects of medication history on midlatency auditory evoked responses in schizophrenia. Schizophr Res. 11:1994;251-258.
42. Erwin R.J., Turetsky B.I., Moberg P., Gur R.C., Gur R.E. P50 abnormalities in schizophrenia Relationship to clinical and neuropsychological indices of attention . Schizophr Res. 33:1998;157-168.
43. Eslinger P.J., Biddle K.R., Grattan L.M. Cognitive and social development in children with prefrontal cortex lesions. Krasnegor N.A., Lyon G.R., Goldman-Rakic P.S. Development of the Prefrontal Cortex Evolution, Neurobiology, and Behavior . 1997;295-336 Paul H. Brookes Publishing Co, Baltimore.
44. Fein G., Biggins C., MacKay S. Cocaine abusers have reduced auditory P50 amplitude and suppression compared to both normal controls and alcoholics. Biol Psychiatry. 39:1996;955-965.
45. Finkenzeller P, Keidel WD (1975): Correlates of auditory perception in averaged prestimulatory EEG-DC recordings. In: Quantitative Analysis of the EEG: Methods and Applications. AEG-Telefunken, 1975; reprinted in Keidel W, Kallert S, Korth M, editors. The Physiological Basis of Hearing. Stuttgart: Georg Thieme Verlag, p 198.
46. Finkenzeller P, Keidel WD (1975): Correlates of auditory perception in averaged prestimulatory EEG-DC recordings. In: Quantitative Analysis of the EEG: Methods and Applications. AEG-Telefunken, 1975; reprinted in Keidel W, Kallert S, Korth M, editors. The Physiological Basis of Hearing. Stuttgart: Georg Thieme Verlag, p 198.
47. Franks R., Adler L.E., Waldo M., Alpert J., Freedman R. Neurophysiological studies of sensory gating in mania Comparison with schizophrenia . Biol Psychiatry. 18:1983;989-1005.
48. Frazier C.J., Rollins Y.D., Breese C.R., Leonard S., Freedman R., Dunwiddie T.V. Acetylcholine activates an α-bungarotoxin sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci. 18:1997;1187-1195.
49. Freedman R., Adler L.E., Bickford P., et al. Schizophrenia and nicotinic receptors. Harvard Rev Psychiatry. 2:(4):1994;179-192.
50. Freedman R., Adler L.E., Leonard S. Alternative phenotypes for the complex genetics of schizophrenia. Biol Psychiatry. 45:1999;551-558.
51. Freedman R., Adler L.E., Nagamoto H.T., Waldo M. Selection of digital filtering parameters and P50 amplitude. Biol Psychiatry. 43:1998;921-922.
52. Freedman R., Adler L.E., Waldo M. Gating of the auditory evoked potential in children and adults. Psychophysiology. 24:1987;223-227.
53. Freedman R., Adler L.E., Waldo M., et al. Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects Human recordings, computer stimulation, and an animal model . Arch Gen Psychiat. 53:1996;1114-1121.
54. Freedman R., Adler L.E., Waldo M.C., Pachtman E., Franks R.D. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia Comparison of medicated and drug-free patients . Biol Psychiatry. 18:1983;537-551.
55. Freedman R., Coon H., Myles-Worsley M., et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA. 94:1997;587-592.
56. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry. 38:1995;22-23.
57. Freedman R., Ross R.G., Adler L.E. Physiological indicators of the schizophrenia phenotype. Psychopharmacology Fourth Generation of Progress - CD/ROM . 1999;Raven Press, New York.
58. Freedman R., Stromberg I., Nordstrom A.L., et al. Neuronal development in embryonic brain tissue derived from schizophrenic women and grafted to animal hosts. Schizophr Res. 13:1994;259-270.
59. Freedman R., Waldo M., Adler L., Baker N., Levin D., Deitrich R. Electrophysiological effects of low-dose alcohol on human subjects at high altitude. Alcohol Drug Res. 6:1986;289-297.
60. Fruhstorfer H., Soveri P., Jarvilehto T. Short-term habituation of the auditory evoked response in man. Electroencephalogr Clin Neurophysiol. 28:1970;153-159.
61. Gault J., Robinson M., Berger R., et al. Genomic organization and partial duplication of the human α 7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics. 52:1998;173-185.
62. Gillette G.M., Skinner R.D., Rasco L.M., et al. Combat veterans with posttraumatic stress disorder exhibit decreased habituation of the P1 midlatency auditory evoked potential. Life Sci. 61:(14):1997;1421-1434.
63. Goldstein J.L., Hazzard W.R., Schrott H.G., Bierman E.L., Motulsky A.G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder. J Clin Invest. 51:1973;1544.
64. Gottesman I.I., Shields J. Schizophrenia and Genetics A Twin Study Vantage Point . 1972;Academic Press, New York.
65. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 153:1996;321-330.
66. Green M.F., Marshall B.D. Jr, Wirshing W.C., et al. Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J of Psychiatry. 154:(6):1997;799-804.
67. Griffith J., Freedman R. Normalization of the auditory P50 gating deficit of schizophrenic patients after NREM, but not REM sleep. Psychiatry Res. 56:1995;271-278.
68. Griffith J., Hoffer L.D., Adler L.E., Zerbe G.O., Freedman R. Effects of sound intensity on a midlatency evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Psychophysiology. 32:1995;460-466.
69. Griffith J., O'Neill J.E., Petty F., Garver D., Young D., Freedman R. Nicotine receptor desensitization and sensory gating deficits in schizophrenia. Biol Psychiatry. 44:1998;98-106.
70. Griffith J.M., Waldo M., Adler L.E., Freedman R. Normalization of auditory sensory gating in schizophrenic patients after a brief period for sleep. Psychiatry Res. 49:1993;29-39.
71. Grillon C., Ameli R., Braff D.L. Middle latency auditory evoked potentials (MAEPs) in chronic schizophrenics. Schizophr Res. 5:1991;61-66.
72. Harris J.G., Adler L.E., Young D.A., et al. Neuropsychological dysfunction in parents of schizophrenics. Schizophr Res. 20:1996;253-260.
73. Hershman K.M., Freedman R., Bickford P.C. GABA-B antagonists diminish the inhibitory gating of auditory response in the rat hippocampus. Neurosci Lett. 190:1995;133-136.
74. Hetrick W.P., Sandman C.A., Bunney W.E. Jr, Jin Y., Potkin S.G., White M.H. Gender differences in gating of the auditory evoked potential in normal subjects. Biol Psychiatry. 39:1996;51-58.
75. Holzman P.S., Kringlen E., Matthysse S., et al. A single dominant gene can account for eye tracking dysfunction and schizophrenia in offspring of discordant twins. Arch Gen Psychiatry. 45:1988;641-647.
76. Jerger K., Biggins C., Fein G. P50 suppression is not affected by attentional manipulation. Biol Psychiatry. 31:1992;365-377.
77. Jin Y., Bunney W.E., Sandman C.A., et al. Is P50 suppression a measure of sensory gating in schizophrenia? Biol Psychiatry. 43:(12):1998;873-878.
78. Jin Y., Potkin S.G., Patterson J.V., Sandman C.A., Hetrick W.P., Bunney W.E. Jr. Effects of P50 temporal variability on sensory gating in schizophrenia. Psychiatry Res. 70:(2):1997;71-81.
79. Johnson M., Adler L.E. Transient impairment of P50 auditory sensory gating by a cold-pressor test. Biol Psychiatry. 33:1993;380-387.
80. Judd L.L., McAdams L., Budnick B., Braff D.L. Sensory gating deficit in schizophrenia New results . Am J Psychiatry. 149:1992;488-493.
81. Kang D.-Y., Poole J., McCallin K., Fein G., Vinogradov S. Sensory gating deficit in schizophrenia Relation to catecholamine metabolites . Schizophr Res. 24:1997;234.
82. Kathmann N., Engel R.R. Sensory gating in normals and schizophrenics A failure to find strong P50 suppression in normals . Biol Psychiatry. 27:1990;1216-1226.
83. Kendler K.S., Gruenberg A.M., Tsuang M.T. Psychiatric illness in the first-degree relatives of schizophrenic and surgical control patients A family study using DSM-III criteria . Arch Gen Psychiatry. 42:1985;770-779.
84. Kong A., Cox N.J. Allele-sharing models LOD scores and accurate linkage tests . Am J Hum Genet. 61:(11):1997;1179-1188.
85. Lamberti J.S., Schwarzkopf S.B., Smith D.A., Rilly J., Martin R. Diminished P50 auditory evoked suppression in schizophrenic patients. Biol Psychiatry. 33:1993;117A.
86. Lander E.S. Splitting schizophrenia. Nature (London). 336:1988;105-106.
87. Leonard S., Gault J., Moore T., et al. Further investigation of a chromosome 15 locus in schizophrenia Analysis of affected sibpairs from the NIMH genetics initiative . Neuropsychiatrict Genet. 81:1998;308-312.
88. Luntz-Leybman V., Bickford P.C., Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 587:1992;130-136.
89. Madison D.V., Nicoll R.A. Norepinephrine decreases synaptic inhibition in rat hippocampus. Brain Res. 442:1988;131-138.
90. Mahtani M.M., Widen E., Lehto M., et al. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet. Sep14:1996;90-94.
91. McGhie A., Chapman J.S. Disorders of attention and perception in early schizophrenia. Br J Med Psychol. 34:1961;103-116.
92. McKenna K., Gordon C.T., Rapoport J.L. Childhood onset schizophrenia Timely neurobiological research . J Am Acad Child Adolesc Psychiatry. 33:1994;771-781.
93. Miller C.L., Bickford-Wimer P.C., Leybman V., Adler L.E., Gerhardt G., Freedman R. Phencyclidine induces a physiological feature of psychosis. Neuropharmacology. 31:1992;1041-1048.
94. Miller C.L., Freedman R. The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neuroscience. 69:1995;371-381.
95. Moldin S.O. The maddening hunt for madness genes. Nat Genet. 7:1997;127-129.
96. Myles-Worsley M., Coon H., Byerley W., Waldo M., Young D., Freedman R. Developmental and genetic influences on the P50 sensory gating phenotype. Biol Psychiatry. 39:1996;289-295.
97. Nagamoto H.T., Adler L.E., Hea R.A., Griffith J.M., McRae K., Freedman R. Gating of auditory P50 in schizophrenics Unique effects of clozapine . Biol Psychiatry. 40:1996;181-188.
98. Nagamoto H.T., Adler L.E., McRae K.A., et al. Auditory P50 in schizophrenics on clozapine Improved gating parallels clinical improvement and changes in pMHPG . Neuropsychobiology. 39:1999;10-17.
99. Nagamoto H.T., Adler L.E., Waldo M.C., Freedman R. Sensory gating in schizophrenics and normal controls Effects of changing stimulation . Biol Psychiatry. 25:1989;549-561.
100. National Institute of Mental Health Genetics Workgroup (1997): Genetics and Mental Disorders. Washington, DC: National Institutes of Health, pp 3-23, 47-50.
101. Olincy A., Leonard S., Young D.A., Sullivan B., Freedman R. Decreased bombesin peptide response in schizophrenia. Neuropsychopharmacology. 20:1999;52-59.
102. Olincy A., Ross R.G., Young D.A., Freedman R. Age diminishes performance on an antisaccade eye movement task. Neurobiol Aging. 5:(18):1997;483-489.
103. Olincy A., Ross R.G., Young D.A., Roath M., Freedman R. Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology. 18:1998;174-185.
104. Olincy A., Young D.A., Freedman R. Increased levels of nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiatry. 42:1997;1-5.
105. Papanicolau A.C., Loring D.W., Eisenberg H.M. Age-related differences in recovery cycle of auditory evoked potentials. Neurobiol Aging. 5:1984;291-295.
106. Papanicolau A.C., Loring D.W., Eisenberg H.M. Evoked potential attenuation in the two-tone paradigm. Int J Psychobiol. 3:1985;23-28.
107. Park S., Holzman P.S., Goldman-Rakic P.S. Spatial working memory deficits in the relatives of schizophrenic patients. Arch Gen Psychiatry. 52:1995;821-828.
108. Pfefferbaum A., Ford J.M., White P.M., Roth W.T. P3 in schizophrenia is affected by stimulus modality, response requirements, medication status, and negative symptoms. Arch Gen Psychiatry. 46:1989;1035-1044.
109. Pierrot-Deseilligny C. Saccade and smooth-pursuit impairment after cerebral hemispheric lesions. Eur Neurol. 34:1994;121-134.
110. Radant A.D., Hommer D.W. A quantitative analysis of saccades and smooth pursuit during visual pursuit tracking A comparison of schizophrenics with normals and substance abusing controls . Schizophr Res. 6:1992;225-235.
111. Ross R.G., Harris J.G., Olincy A., Radant A., Adler L.E., Freedman R. Familial transmission of two independent saccadic abnormalities in schizophrenia. Schizophr Res. 30:1998;59-70.
112. Ross R.G., Olincy A., Harris J.G., et al. Evidence for bilineal inheritance of physiological indicators of risk in childhood-onset schizophrenia. Am J Med Genet: Neuropsychiatric Genet. 88:1999;188-199.
113. Ross RG, Olincy A, Harris JG, et al (1999): The effects of age on a smooth pursuit tracking task in adults with schizophrenia and normals. Biol Psychiatry, in press.
114. Ross R.G., Olincy A., Harris J.G., Radant A., Adler L.E., Freedman R. Anticipatory saccades during smooth pursuit eye movements and familial transmission of schizophrenia. Biol Psychiatry. 44:1998;690-697.
115. Ross RG, Olincy A, Radant A (1999): Amplitude criteria and anticipatory saccades during smooth pursuit eye movements in schizophrenia. Psychophysiology, in press.
116. Ross R.G., Radant A.D., Hommer D.W. A developmental study of smooth pursuit eye movements in normal children from 7 to 15 years of age. J Child Adolesc Psychiatry. 32:1993;783-791.
117. Roth W.T., Kopell B.S. The auditory evoked response to repeated stimuli during a vigilance task. Psychophysiology. 6:1969;301-309.
118. Schiebel R.S., Levin H.S. Cognitive and social development in children with prefrontal cortex lesions. Krasnegor N.A., Lyon G.R., Goldman-Rakic P.S. Development of the Prefrontal Cortex Evolution, Neurobiology, and Behavior . 1997;283-294 Paul H. Brookes Publishing Co, Baltimore.
119. Sham P.C., Morton N.E., Muir W.J., et al. Segregation analysis of complex phenotypes An application to schizophrenia and auditory P300 latency . Psychiatric Genet. 4:1994;29-38.
120. Shihabuddin L., Silverman J.M., Buchsbaum M.S., et al. Ventricular enlargement associated with linkage marker for schizophrenia-related disorders in one pedigree. Mol Psychiatry. 1:(3):1996;215-222.
121. Siegel C., Waldo M., Mizner G., Adler L.E., Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives. Arch Gen Psychiatry. 41:1984;607-612.
122. Smith D.A., Boutros N.N., Schwarzkopf S.B. Reliability of P50 auditory event-related potential indices of sensory gating. Psychophysiology. 31:1994;495-502.
123. Stevens K.E., Freedman R., Collins A.C., et al. Genetic correlation of hippocampal auditory evoked response and alpha-bungarotoxin binding in inbred mouse strains. Neuropsychopharmacol. 15:1996;152-162.
124. Stevens K.E., Kem W.R., Mahnir V.M., Freedman R. Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology. 136:1998;320-327.
125. Stevens K.E., Meltzer J., Stryker S.L., Rose G.M. Disruption of sensory gating by the alpha-2 selective noradrenergic antagonist yohimbine. Biol Psychiatry. 33:1993;130-132.
126. Stevens K.E., Wear K.D. Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory gating in two animal models. Pharmacol Biochem Behav. 57:1997;869-874.
127. Straumanis J.J., Shagass C., Roemer R.A. Influence of antipsychotic and antidepressant drugs on evoked potential correlates of psychosis. Biol Psychiatry. 17:1982;1101.
128. Tsuang M.T., Lyons M.J., Faraone S.V. Heterogeneity of schizophrenia Conceptual models and analytic strategies . Br J Psychiatry. 156:1990;17-26.
129. Venables P. Input dysfunction in schizophrenia. Maher B.A. Progress in Experimental Personality Research. 1964;1-47 Academic Press, Orlando, FL.
130. Vinogradov S., Solomon S., Ober B.A., Biggins C.A., Shenaut G.K., Fein G. Do semantic priming effects correlate with sensory gating in schizophrenia? Biol Psychiatry. 39:1996;821-824.
131. Waldo M., Carey G., Myles-Worsley M., et al. Co-distribution of sensory gating deficit and schizophrenia in multi-affected families. Psychiatry Res. 39:1991;257-268.
132. Waldo M.C., Cawthra E., Adler L.E., et al. Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings. Schizophr Res. 12:1994;93-106.
133. Waldo M.C., Graze K., de Graff Bender S., Adler L.E., Freedman R. Premenstrual mood changes and gating of the auditory evoked potential. Psychoneuroendocrinology. 12:1987;35-40.
134. Waldo M., Myles-Worsley M., Madison A., Byerley W., Freedman R. Sensory gating deficits in parents of schizophrenics. Am J Med Genet. 60:1995;506-511.
135. Ward P.B., Hoffer L.D., Liebert B.J., Catts S.V., O'Donnell M., Adler L.E. Replication of a P50 auditory gating deficit in Australian patients with schizophrenia. Psychiatry Res. 64:1996;121-135.
136. Wilson C.L., Babb T.L., Halgren E., Wang M.L., Crandall P.H. Habituation of human neuronal limbic response to sensory stimulation. Exp Neurol. 84:1984;74-97.
137. Yee C.M., Nuechterlein K.H., Morris S.E., White P.M. P50 suppression in recent-onset schizophrenia Clinical correlates and risperidone effects . J Abnorm Psychol. 107:1998;691-698.
138. Young D., Waldo M., Rutledge J.H., Freedman R. Heritability of inhibitory gating of the P50 auditory evoked potential in monozygotic and dizygotic twins. Neuropsychobiology. 33:1996;113-117.
139. Zouridakis G., Boutros N.N., Jansen B.H. A fuzzy clustering approach to study the auditory P50 component in schizophrenia. Psychiatry Res. 69:1997;169-181.